Use of ticlopidine and cilostazol after intracoronary drug-eluting stent placement in a patient with previous clopidogrel-induced thrombotic thrombocytopenic purpura: A case report

Journal of Invasive Cardiology

Volumn 18, Issue 7, 2006, Pages

  Patel, Taral N ^a   Kreindel, Mark ^a   Lincoff, A Michael ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; CORTICOSTEROID; DIURETIC AGENT; ENOXAPARIN; FUROSEMIDE; HEPARIN; ISOSORBIDE MONONITRATE; METOPROLOL; NITRATE; RAPAMYCIN; TICLOPIDINE;

ACUTE KIDNEY FAILURE; AGED; ANAMNESIS; ARTICLE; BLOOD SMEAR; CASE REPORT; CONGESTIVE HEART FAILURE; CORONARY ARTERY OBSTRUCTION; DRUG EFFECT; DRUG ELUTING STENT; DRUG SAFETY; DYSPNEA; ECCHYMOSIS; FEMALE; FEVER; FOLLOW UP; HEART INFARCTION; HEMOLYTIC ANEMIA; HOSPITAL DISCHARGE; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; PERCUTANEOUS CORONARY INTERVENTION; PLASMAPHERESIS; THROMBOCYTOPENIA; THROMBOSIS PREVENTION; THROMBOTIC THROMBOCYTOPENIC PURPURA; UNSTABLE ANGINA PECTORIS;

ADAM PROTEINS; AGED; APOPTOSIS; ASPIRIN; AUTOANTIBODIES; CORONARY ARTERY BYPASS; CORONARY DISEASE; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; PLASMAPHERESIS; PLATELET AGGREGATION INHIBITORS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; STENTS; TETRAZOLES; TICLOPIDINE;

EID: 33745750801     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Moake JL. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. Arch Pathol Lab Med 2002;126:1430-1433.
2. McCarthy LJ, Dlott JS, Orazi A, et al. Thrombotic thrombocytopenic purpura: yesterday, today, tomorrow. Ther Apher Dial 2004;8:80-86.
3. Bennett CL, Weinberg PD, Rozenberg-Ben-Dror K, et al. Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Am Intern Med 1998;128:541-544.
4. Steinhubl SR, Tan WA, Foody JM, Topol EJ. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. JAMA 1999;281:806-810.
5. Bennett CL, Connors JM, Carwile JM, et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 2000;342:1773-1777.
6. Majhail NS, Lichtin AE. Clopidogrel and thrombotic thrombocytopenic purpura: No clear case for causality. Cleve Clin J Med 2003;70:466-470.
7. Dlott JS, Danielson CF, Blue-Hnidy DE, McCarthy LJ. Drug-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a concise review. Ther Apher Dial 2004;8:102-111.
8. Tsai HM, Rice L, Sarode R, et al. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura. Ann Intern Med 2000;132:794-799.
9. Evens AM, Kwaan HC, Kaufman DB, Bennett CL. TTP/HUS occurring in a simultaneous pancreas/kidney transplant recipient after clopidognel treatment: Evidence of a nonimmunological etiology. Transplantation 2002;74:885-887.
10. Mauro M, Zlatopolskiy A, Raife TJ, Laurence J. Thienopyridine-linked thrombotic microangiopathy: Association with endothelial cell apoptosis and activation of MAP kinase signalling cascades. Br J Haematol 2004;124:200-210.
11. Bennett CL, Davidson CJ, Raisch DW, et al. Thrombotic thrombocytopenic purpura associated with tidopidine in the setting of coronary artery stents and stroke prevention. Arch Intern Med 1999;159:2524-2528.
12. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-1521.
13. Ong AT, McFadden EP, Regar E, et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005;45:2088-2092.
14. Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005;45:947-953.
15. Park SJ, Shim WH, Ho DS, et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Eng J Med 2003;348:1537-1545.